The Roskamp Institute
Michael Mullan is a co-founder and executive director of Roskamp Institute since 2003. Michael served as the chief executive officer of Archer Pharmaceuticals from 2008. In 2018, they became the chief executive officer of Bio SRQ, Inc. Additionally, they are a co-founder and executive director of AltPep from 2019.
Michael Mullan attended the Royal Free School of Medicine, London University from 1978 to 1984. No specific degree or field of study was mentioned.
The Roskamp Institute
The Roskamp Institute is devoted to understanding causes of and finding cures for neuropsychiatric and neurodegenerative disorders and addictions. Based in Sarasota, Florida, the Institute utilizes a broad range of scientific approaches to understanding the causes of and potential therapies for these disorders with an emphasis on Alzheimer's disease. Headed by Dr. Michael Mullan and Dr. Fiona Crawford, the institute employs experienced and interdisciplinary scientists and technicians and houses state-of-the-art research labs and equipment to conduct scientific research. The quality of research performed at the institute reflects its motto: "Better science. Real discovery."